We are live on ! Find out more
BMCM

Bryn Mawr Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+26.05%
3 Year Est. Return
+71.45%
5 Year Est. Return
+76.08%
10 Year Est. Return
AUM
$110M
AUM Growth
+$33.9M
Cap. Flow
+$32.8M
Cap. Flow %
29.76%
Top 10 Hldgs %
66.23%
Holding
95
New
27
Increased
26
Reduced
22
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 3.87%
2 Communication Services 3.53%
3 Technology 3.01%
4 Financials 2.53%
5 Consumer Discretionary 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBEF icon
76
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$206K 0.19%
+6,706
New +$211K
V icon
77
Visa
V
$675B
$202K 0.18%
+1,689
New +$205K
GE icon
78
GE Aerospace
GE
$380B
$201K 0.18%
3,147
-550
-15% -$40.8K
FENY icon
79
Fidelity MSCI Energy Index ETF
FENY
$2.03B
$198K 0.18%
10,598
FRBK
80
DELISTED
Republic First Bancorp Inc
FRBK
$176K 0.16%
20,253
BCS icon
81
Barclays
BCS
$94.3B
$129K 0.12%
11,416
SIRI icon
82
SiriusXM
SIRI
$9.7B
$102K 0.09%
1,633
+1
+0.1% +$60
S
83
DELISTED
Sprint Corporation
S
$98K 0.09%
20,000
FBIO icon
84
Fortress Biotech
FBIO
$91.4M
$82K 0.07%
1,197
+214
+22% +$13.5K
NBSE
85
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3K ﹤0.01%
+36
New +$5.35K
AMLP icon
86
Alerian MLP ETF
AMLP
$13.3B
-2,867
Closed -$161K
COF icon
87
Capital One
COF
$134B
-2,382
Closed -$202K
CVS icon
88
CVS Health
CVS
$122B
-2,516
Closed -$205K
D icon
89
Dominion Energy
D
$59.1B
-2,969
Closed -$228K
MET icon
90
MetLife
MET
$61.7B
-3,951
Closed -$205K
PFF icon
91
iShares Preferred and Income Securities ETF
PFF
$13.2B
-5,821
Closed -$226K
REGN icon
92
Regeneron Pharmaceuticals
REGN
$83.2B
-11,542
Closed -$5.16M
UNH icon
93
UnitedHealth
UNH
$371B
-3,519
Closed -$689K
URG
94
Ur-Energy
URG
$564M
-10,000
Closed -$6K
ARLZ
95
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
-113,752
Closed -$260K

Similar funds

Bryn Mawr Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Bryn Mawr Capital Management held 95 positions worth $110M, up 44% from $76.2M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bryn Mawr Capital Management deployed $32.8M of net new capital in Q1 2018, opening 27 new positions and adding to 26 existing holdings. Its largest new stake was Vanguard Dividend Appreciation ETF: 126,391 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 3.9% of assets, down from 13% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was iShares S&P Mid-Cap 400 Growth ETF, an estimated $1.13M trimmed.

  • Bryn Mawr Capital Management's largest Q1 2018 buy was Vanguard Dividend Appreciation ETF: 126,391 shares worth $12.8M.
  • Bryn Mawr Capital Management added most to iShares Core S&P 500 ETF in Q1 2018, an estimated $14.6M increase.
  • Bryn Mawr Capital Management's biggest Q1 2018 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $1.13M.
  • Bryn Mawr Capital Management fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $5.16M.
  • Bryn Mawr Capital Management's ten largest holdings make up 66% of its $110M portfolio in Q1 2018.
  • Bryn Mawr Capital Management opened 27 new positions and closed 10 in Q1 2018.
  • Bryn Mawr Capital Management's portfolio value rose 44% quarter-over-quarter to $110M.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2018, filed 11 May 2018.